Clinipace is an emerging provider of electronic data capture (EDC). It’s targeting the practice of “change orders” that significantly change the scope and cost of the technology. On August 26, at 2:00 p.m. Eastern, the firm is running a webinar on its fixed-price approach. “We believe there should be no surprises in how and what you pay. Take our challenge by bringing us a fully-loaded quote [including mid-study changes that you know they will charge you for] and we’ll beat it,” the company says. Click here to register.

Combining imaging and cardiovascular testing, ICON announced that its imaging division is the first in the industry to offer quantitative coronary angiographic (QCA) analysis inside an integrated electronic case report form (eCRF). The QCA element has been provided by Sanders Data Systems. “Clinical trials incorporating QCA have made a significant impact in cardiovascular drug and device development,” commented Jonathan Goldman, chief medical officer, ICON Medical Imaging. “Building QCA capabilities into [our eCRF solution] represents the latest in a series of innovations designed to boost the integrity and reproducibility of clinical trial data, and enhances our leadership in the field of imaging within clinical research.” Here’s the release.

Octagon Research named Terek Peterson director, clinical programming. He had been senior manager, statistical programming global biometrics at Shire.

Is Canada’s drug safety system likely to be improved? Not according to Alan Cassels. “The business plan behind this network called for about $20 million per year, but Health Canada announced an immediate five percent of that ($1 million dollars) to get things up and running,” his article notes.

The executive director of the Drug Information Association (DIA) has suddently resigned. Linda McGoldrick just arrived at the organization in January, as we reported here. In her place, DIA named an interim executive director, William Brassington, also the organization’s CFO.

The American Health Information Community (AHIC) is shutting down. That’s been long planned. The question now is what should take its place. An advisory board under the aegis of the U.S. Dept. of Health and Human Services, AHIC had sought to work behind the scenes to ensure all Americans have access to electronic health records by 2014. We won’t hold our breath. But we were interested to read this comment on AHIC’s future from Clinical Data Interchange Standards Consortium (CDISC) president and CEO Becky Kush: “We can bring additional resources to the party,” she said.

It’s been a big week in Lilly-related outsourcing news. The company sold a big lab to Covance last week. Now it will turn its data management to i3 Statprobe, echoing a similar arrangement between Wyeth and Accenture, but with the twist that the work will remain in the U.S. in Indiana. “i3 is pleased to be selected by a company of Lilly’s stature, and believes it reflects our fundamental commitment to the high level of customer service that the i3 Statprobe team has provided to Lilly over the years and our strategy of operational, clinical and scientific specialization,” said Glenn Bilawsky, i3’s CEO.  “We are honored to bring this approach more broadly to a customer with the profile of Eli Lilly.” Here’s the statement and an article from a local newspaper.

Have a news release? Send it to .